Vivos Therapeutics (VVOS) Goodwill (2019 - 2026)

Vivos Therapeutics (VVOS) has reported Goodwill for 8 consecutive years, with $8.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Goodwill rose 1.18% year-over-year to $8.6 million in Q2 2026; TTM through Jun 2026 was $8.6 million, a 1.18% increase from a year earlier, with the FY2025 full-year figure at $8.6 million, up 202.5% from the prior year.
• Goodwill was $8.6 million for Q2 2026 at Vivos Therapeutics, roughly flat from $8.6 million in the prior quarter.
• Over five years, Goodwill peaked at $8.6 million in Q4 2025 and troughed at $2.8 million in Q1 2022.
• A 5-year average of $4.4 million and a median of $2.8 million in 2022 frame the typical range for Goodwill.
• Across the five-year window, Goodwill dropped 0.0% in 2022 and surged 202.5% in 2025, its largest moves.
• Over 5 years, Goodwill stood at $2.8 million in 2022, then changed by 0.0% to $2.8 million in 2023, then changed by 0.0% to $2.8 million in 2024, then surged by 202.5% to $8.6 million in 2025, then changed by 0.0% to $8.6 million in 2026.
• The last three Goodwill figures came in at $8.6 million (Q2 2026), $8.6 million (Q1 2026), and $8.6 million (Q4 2025), per Business Quant data.